Table 2.
Data | T0 | T1 | T2 | T3 | P value |
---|---|---|---|---|---|
TIV (ml) | 400 [333; 423] | 366 [297; 602] | 420 [325; 620] | 364 [274; 468] | 0.132 |
Dorsal | 164 [106; 215] | 153 [109; 316] | 166 [116; 280] | 143 [109; 254] | 0.114 |
Ventral | 206 [169; 266] | 213 [164; 328] | 239 [181; 333] | 214 [156; 240] | 0.125 |
∆EELI (ml) | 0 [0; 0] | 258 [56; 332]a | 276 [148; 451]b | 290 [184; 412]c | < 0.001 |
Dorsal | 0 [0; 0] | 154 [72; 202]a | 143 [42; 327]b | 133 [107; 232]c | < 0.001 |
Ventral | 0 [0; 0] | 73 [− 16; 157]a | 76 [38; 173]b | 77 [58; 206]c | < 0.001 |
Inhomogeneity index | 70 [41; 92] | 55 [40; 69] | 60 [38; 72] | 67 [39; 73] | 0.114 |
All data are expressed as median [25th–75th percentile]
T0 baseline assessment, T1 assessment soon after the end of the treatment, T2 assessment 1 h after the end of the treatment, T3 assessment 3 h after the end of the treatment, TIV tidal impedance variation, ∆EELI difference of end-expiratory lung impedance from T0
ap < 0.05 T1 vs. T0
bp < 0.05 T2 vs. T0
cp < 0.05 T3 vs. T0